TGFB1 and neoplasm: It has been shown that mice whose T cells have been rendered resistant to TGF-β through the production of a dominant-negative TGF-β receptor transgene can develop an immunological response, eradicate the tumor burden, and survive with TGF-β-producing tumors [50,51].